We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: PayPal, Comcast, Novartis, BlackRock and FedEx
Read MoreHide Full Article
For Immediate Release
Chicago, IL – November 3, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: PayPal Holdings, Inc. (PYPL - Free Report) , Comcast Corporation (CMCSA - Free Report) , Novartis AG (NVS - Free Report) , BlackRock, Inc. (BLK - Free Report) and FedEx Corporation (FDX - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Analyst Reports for PayPal, Comcast and Novartis
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including PayPal, Comcast and Novartis. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
PayPal shares have been stellar performers lately, bu they have modestly lagged the Zacks Internet Software industry in the year-to-date period (+72% vs. +74.1%). The Zacks analyst believes that PayPal is benefiting from robust growth in total payments volume owing to increasing net new active accounts.
Further, strengthening customer engagement on the company’s platform is a major positive. Furthermore, Venmo’s improving monetization efforts and rising adoption rate across various platforms are aiding the total active accounts. Additionally, growing momentum of core peer to peer and PayPal Checkout experiences is a tailwind.
Also, benefits from Honey buyout are positives. However, increasing credit loss reserves owing to macroeconomic projections on account of coronavirus is a serious matter of concern. Also, intensifying digital payment competition is a risk.
Shares of Comcast have lost -3.7% over the past year against the Zacks Cable Television industry’s rise of +2.5%. The Zacks analyst believes that growing high-speed Internet user base due to coronavirus, solid demand for Xfinity X1 and Flex services and newly launched Peacock ad-supported streaming service are key catalysts for Comcast’s growth.
Comcast’s third-quarter 2020 results were driven by solid growth in high-speed Internet, Business Services, Wireless and Sky segments. The growth in advertising revenues reflected an increase in political advertising revenues. However, Comcast persistently suffered video-subscriber attrition due to cord-cutting.
Moreover, its Universal Studios Hollywood theme park remains closed. Further, Comcast expects Sky EBITDA for the fourth quarter to decline. Weakness in film business is also a headwind. Moreover, the balance sheet remains significantly leveraged, which is a concern.
Novartis shares have lost -7.1% over the past six months against the Zacks Large-Cap Pharmaceuticals industry’s fall of -6%. The Zacks analyst believes that new launches like Piqray, Mayzent and Beovu should boost sales despite a slowdown due to the pandemic. The biosimilars portfolio also gains traction with new approvals and is expected to drive growth.
Novartis’ third-quarter results were mixed as sales were hit by the coronavirus pandemic but earnings beat expectations. Particularly, the dermatology, ophthalmology and Sandoz retail businesses were affected. Entresto maintained momentum on increased patient share across markets, although Cosentyx’s sales were soft.
Contributions from Kisqali and gene therapy, Zolgensma, have also boosted the performance in recent times. However, Sandoz’s generics business has been soft in the past few quarters. Moreover, pipeline setbacks and generic competition for key drugs are concerning.
Other noteworthy reports we are featuring today include BlackRock and FedEx.
The Hottest Tech Mega-Trend of All
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
The Zacks Analyst Blog Highlights: PayPal, Comcast, Novartis, BlackRock and FedEx
For Immediate Release
Chicago, IL – November 3, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: PayPal Holdings, Inc. (PYPL - Free Report) , Comcast Corporation (CMCSA - Free Report) , Novartis AG (NVS - Free Report) , BlackRock, Inc. (BLK - Free Report) and FedEx Corporation (FDX - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Analyst Reports for PayPal, Comcast and Novartis
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including PayPal, Comcast and Novartis. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
PayPal shares have been stellar performers lately, bu they have modestly lagged the Zacks Internet Software industry in the year-to-date period (+72% vs. +74.1%). The Zacks analyst believes that PayPal is benefiting from robust growth in total payments volume owing to increasing net new active accounts.
Further, strengthening customer engagement on the company’s platform is a major positive. Furthermore, Venmo’s improving monetization efforts and rising adoption rate across various platforms are aiding the total active accounts. Additionally, growing momentum of core peer to peer and PayPal Checkout experiences is a tailwind.
Also, benefits from Honey buyout are positives. However, increasing credit loss reserves owing to macroeconomic projections on account of coronavirus is a serious matter of concern. Also, intensifying digital payment competition is a risk.
(You can read the full research report on PayPal here >>>)
Shares of Comcast have lost -3.7% over the past year against the Zacks Cable Television industry’s rise of +2.5%. The Zacks analyst believes that growing high-speed Internet user base due to coronavirus, solid demand for Xfinity X1 and Flex services and newly launched Peacock ad-supported streaming service are key catalysts for Comcast’s growth.
Comcast’s third-quarter 2020 results were driven by solid growth in high-speed Internet, Business Services, Wireless and Sky segments. The growth in advertising revenues reflected an increase in political advertising revenues. However, Comcast persistently suffered video-subscriber attrition due to cord-cutting.
Moreover, its Universal Studios Hollywood theme park remains closed. Further, Comcast expects Sky EBITDA for the fourth quarter to decline. Weakness in film business is also a headwind. Moreover, the balance sheet remains significantly leveraged, which is a concern.
(You can read the full research report on Comcast here >>>)
Novartis shares have lost -7.1% over the past six months against the Zacks Large-Cap Pharmaceuticals industry’s fall of -6%. The Zacks analyst believes that new launches like Piqray, Mayzent and Beovu should boost sales despite a slowdown due to the pandemic. The biosimilars portfolio also gains traction with new approvals and is expected to drive growth.
Novartis’ third-quarter results were mixed as sales were hit by the coronavirus pandemic but earnings beat expectations. Particularly, the dermatology, ophthalmology and Sandoz retail businesses were affected. Entresto maintained momentum on increased patient share across markets, although Cosentyx’s sales were soft.
Contributions from Kisqali and gene therapy, Zolgensma, have also boosted the performance in recent times. However, Sandoz’s generics business has been soft in the past few quarters. Moreover, pipeline setbacks and generic competition for key drugs are concerning.
(You can read the full research report on Novartis here >>>)
Other noteworthy reports we are featuring today include BlackRock and FedEx.
The Hottest Tech Mega-Trend of All
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.